What changed
$HLT — Halts CPU execution until reset or interrupt.
🎯 Q1 FY26 | Rev $1B | EPS $2.01 vs $1.97 🟢 | Margin 57.4%
💡 Consensus expects steady RevPAR growth and margin expansion from Hilton's asset-light model. The 1.78% EPS beat is modest and already priced in. The market may be underestimating the impact of slowing U.S.
🏢 Business Quality: 8/10 | Valuation: fair
📉 Reward/Risk: Upside 10% to $372 (25x forward EPS) vs. downside 15% to $287 (19x forward EPS) if RevPAR decelerates. Ratio 0.67:1, unfavorable.
🔮 Catalyst: No near-term catalyst. Q2 2026 earnings (late July) will show RevPAR trends and forward guidance. Metric to watch: system-wide comparable RevPAR growth vs. 3.6% in Q1. Failure signal: RevPAR growth below 2% or negative guidance revision.
💰 Entry: Current price $338.22 is near the upper end of its 52-week range. Not attractive for new long entry.
Also in play: $CNHI $DE $CAT $TEX $OSK $CMI